Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages

Leukemia Research

Volumn 34, Issue 1, 2010, Pages 63-68

  Chapiro, Elise ^a,b   Leporrier, Nathalie ^c   Radford Weiss, Isabelle ^b,d   Bastard, Christian ^e   Mossafa, Hossein ^f   Leroux, Dominique ^g   Tigaud, Isabelle ^h   De Braekeleer, Marc ⁱ   Terré, Christine ^j   Brizard, Françoise ^k   Callet Bauchu, Evelyne ^h   Struski, Stéphanie ^l   Veronese, Lauren ^m   Fert Ferrer, Sandra ⁿ   Taviaux, Sylvie ^o   Lesty, Claude ^a   Davi, Frédéric ^a   Merle Béral, Hélène ^a   Bernard, Olivier A ^b   Sutton, Laurent ^p   Raynaud, Sophie D ^q   Nguyen Khac, Florence ^a,b   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e CENTRE HENRI BECQUEREL   (France)

^f LABORATOIRE CERBA   (France)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

^h CENTRE HOSPITALIER LYON SUD   (France)

ⁱ BREST UNIVERSITY HOSPITAL   (France)

^j CH Versailles   (France)

^k POITIERS UNIVERSITY HOSPITAL   (France)

^l CHU PURPAN   (France)

^m UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

ⁿ Laboratoire de Génétique Chromosomique   (France)

^o MONTPELLIER UNIVERSITY HOSPITAL   (France)

^p CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^q PASTEUR HOSPITAL   (France)

more..

Author keywords

2p gain; CLL; MYCN; REL

Indexed keywords

MESSENGER RNA; MYC PROTEIN; TRANSCRIPTION FACTOR REL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CHROMOSOME 2P; CHROMOSOME ABERRATION; CHROMOSOME ARM; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC GAIN; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; MAJOR CLINICAL STUDY; MYELOID LEUKEMIA; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 2; GENE DOSAGE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;

EID: 73549103619     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.03.042     Document Type: Article

References (18)

1. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M.T., Monconduit M., Belabbes S., and Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48 (1981) 198-206
2. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., Dohner K., Bentz M., and Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343 (2000) 1910-1916
3. Moreau E.J., Matutes E., A'Hern R.P., Morilla A.M., Morilla R.M., Owusu-Ankomah K.A., Seon B.K., and Catovsky D. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol 108 (1997) 378-382
4. Kawanishi H., Takahashi T., Ito M., Watanabe J., Higashi S., Kamoto T., Habuchi T., Kadowaki T., Tsujimoto G., Nishiyama H., and Ogawa O. High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers. Cancer Sci 97 (2006) 746-752
5. Callier P., Faivre L., Thauvin-Robinet C., Marle N., Mosca A.L., D'Athis P., Guy J., Masurel-Paulet A., Joly L., Guiraud S., Teyssier J.R., Huet F., and Mugneret F. Array-CGH in a series of 30 patients with mental retardation, dysmorphic features, and congenital malformations detected an interstitial 1p22.2-p31.1 deletion in a patient with features overlapping the Goldenhar syndrome. Am J Med Genet A 146A (2008) 2109-2115
6. Larrabee P.B., Johnson K.L., Pestova E., Lucas M., Wilber K., LeShane E.S., Tantravahi U., Cowan J.M., and Bianchi D.W. Microarray analysis of cell-free fetal DNA in amniotic fluid: a prenatal molecular karyotype. Am J Hum Genet 75 (2004) 485-491
7. Ghia P., Stamatopoulos K., Belessi C., Moreno C., Stella S., Guida G., Michel A., Crespo M., Laoutaris N., Montserrat E., Anagnostopoulos A., Dighiero G., Fassas A., Caligaris-Cappio F., and Davi F. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 105 (2005) 1678-1685
8. Schwaenen C., Nessling M., Wessendorf S., Salvi T., Wrobel G., Radlwimmer B., Kestler H.A., Haslinger C., Stilgenbauer S., Dohner H., Bentz M., and Lichter P. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 101 (2004) 1039-1044
9. Mayr C., Speicher M.R., Kofler D.M., Buhmann R., Strehl J., Busch R., Hallek M., and Wendtner C.M. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 107 (2006) 742-751
10. Haferlach C., Dicker F., Schnittger S., Kern W., and Haferlach T. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 21 (2007) 2442-2451
11. Pfeifer D., Pantic M., Skatulla I., Rawluk J., Kreutz C., Martens U.M., Fisch P., Timmer J., and Veelken H. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 109 (2007) 1202-1210
12. Bea S., Lopez-Guillermo A., Ribas M., Puig X., Pinyol M., Carrio A., Zamora L., Soler F., Bosch F., Stilgenbauer S., Colomer D., Miro R., Montserrat E., and Campo E. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am J Pathol 161 (2002) 957-968
13. Seifert M., and Reichrath J. The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer. J Mol Histol 37 (2006) 301-307
14. Schwab M. MYCN in neuronal tumours. Cancer Lett 204 (2004) 179-187
15. Wlodarska I., Dierickx D., Vanhentenrijk V., Van Roosbroeck K., Pospisilova H., Minnei F., Verhoef G., Thomas J., Vandenberghe P., and De Wolf-Peeters C. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 111 (2008) 5683-5690
16. Forconi F., Rinaldi A., Kwee I., Sozzi E., Raspadori D., Rancoita P.M., Scandurra M., Rossi D., Deambrogi C., Capello D., Zucca E., Marconi D., Bomben R., Gattei V., Lauria F., Gaidano G., and Bertoni F. Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion. Br J Haematol (2008)
17. Barth T.F., Martin-Subero J.I., Joos S., Menz C.K., Hasel C., Mechtersheimer G., Parwaresch R.M., Lichter P., Siebert R., and Mooller P. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood 101 (2003) 3681-3686
18. Houldsworth J., Olshen A.B., Cattoretti G., Donnelly G.B., Teruya-Feldstein J., Qin J., Palanisamy N., Shen Y., Dyomina K., Petlakh M., Pan Q., Zelenetz A.D., Dalla-Favera R., and Chaganti R.S. Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood 103 (2004) 1862-1868